PCM
ZYME icon

PenderFund Capital Management’s Zymeworks ZYME Stock Holding History

PenderFund Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-325,058
Closed -$5.36M – 74
2018
Q1 		$5.36M Buy
+325,058
New +$3.52M 2.23% 13

Other funds holding ZYME

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

PenderFund Capital Management's ZYME Position: Q2 2018 in Review

PenderFund Capital Management sold out of Zymeworks (ZYME) in Q2 2018, closing a stake of 325,058 shares — an estimated $5.36M sold.

PenderFund Capital Management first reported a position in ZYME in Q1 2018 and held it in 1 quarter. The position peaked at $5.36M in Q1 2018. 43 funds tracked by Wall St. Rank hold ZYME as of Q2 2018.

  • PenderFund Capital Management reported no remaining Zymeworks position as of Q2 2018 after selling out during the quarter.
  • PenderFund Capital Management sold 325,058 Zymeworks shares in Q2 2018, an estimated $5.36M.
  • PenderFund Capital Management first reported a position in Zymeworks in Q1 2018 and held it in 1 quarter.
  • PenderFund Capital Management's Zymeworks position peaked at $5.36M in Q1 2018.
  • 43 funds tracked by Wall St. Rank held Zymeworks as of Q2 2018.

Based on PenderFund Capital Management's 13F filing for Q2 2018, filed 17 Jul 2018.